Cancer-epigenetics comes of age

The discovery of numerous hypermethylated promoters of tumour–suppressor genes, along with a better understanding of gene–silencing mechanisms, has moved DNA methylation from obscurity to recognition as an alternative mechanism of tumour–suppressor inactivation in cancer. Epigenetic events can also facilitate genetic damage, as illustrated by the increased mutagenicity of 5–methylcytosine and the silencing of the MLH1 mismatch repair gene by DNA methylation in colorectal tumours. We review here current mechanistic understanding of the role of DNA methylation in malignant transformation, and suggest Knudson's two–hit hypothesis should now be expanded to include epigenetic mechanisms of gene inactivation.

[1]  G. Martin,et al.  Methylation of the Hprt gene on the inactive X occurs after chromosome inactivation , 1987, Cell.

[2]  P. Jones,et al.  DNA methylation errors and cancer. , 1996, Cancer research.

[3]  G. Prendergast,et al.  Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. , 1991, Science.

[4]  Peter A. Jones,et al.  The Mutational Burden of 5-Methylcytosine , 1996 .

[5]  P. Pollock,et al.  Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds , 1997, Oncogene.

[6]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[7]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[8]  R. Beart,et al.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.

[9]  S. Clark,et al.  Sp1 binding is inhibited by mCpmCpG methylation , 1997 .

[10]  P. Laird,et al.  COBRA: a sensitive and quantitative DNA methylation assay. , 1997, Nucleic acids research.

[11]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[12]  A. Bird,et al.  MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.

[13]  P. Jones,et al.  Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). , 1997, Nucleic acids research.

[14]  Rudolf Jaenisch,et al.  Role for DNA methylation in genomic imprinting , 1993, Nature.

[15]  Y. Hosoya,et al.  Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Razin,et al.  DNA methylation and gene expression , 1991, Microbiological reviews.

[17]  A. Riggs,et al.  X chromosome inactivation and DNA methylation. , 1993, EXS.

[18]  E. Selker,et al.  DNA methylation inhibits elongation but not initiation of transcription in Neurospora crassa. , 1997, Genes & development.

[19]  N. Hayward,et al.  Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. , 1997, Cancer research.

[20]  J. Herman,et al.  Association between CpG island methylation and microsatellite instability in colorectal cancer. , 1997, Cancer research.

[21]  S N Thibodeau,et al.  Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. , 1998, Cancer research.

[22]  C. Harris,et al.  Mutational spectrum of the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Drug metabolism reviews.

[23]  P. Jones,et al.  Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. , 1998, Cancer research.

[24]  A. Bird.  CpG-rich islands and the function of DNA methylation , 1986, Nature.

[25]  J. Herman,et al.  Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. , 1998, Cancer research.

[26]  K. Kinzler,et al.  DNA methylation and genetic instability in colorectal cancer cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Lubahn,et al.  Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. , 1997, Cancer research.

[28]  M. Ehrlich,et al.  Binding of AP-1/CREB proteins and of MDBP to contiguous sites downstream of the human TGF-beta 1 gene. , 1994, Biochimica et biophysica acta.

[29]  H. Prydz,et al.  A methylated CpG island 3' in the apolipoprotein-E gene does not repress its transcription. , 1993, Human molecular genetics.

[30]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.

[31]  S. Baylin,et al.  Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Jones,et al.  The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. , 1998, Cancer research.

[33]  A. Feinberg,et al.  The genetics of BWS associated tumors , 1999 .

[34]  V. Kosma,et al.  Hypermethylation of the APC (adenomatous Polyposis Coli) gene promoter region in human colorectal carcinoma , 1997, International journal of cancer.

[35]  D. Barlow,et al.  Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. , 1993, Cell.

[36]  H. Prydz,et al.  CpG islands as gene markers in the human genome. , 1992, Genomics.

[37]  V. Chapman,et al.  Use of a HpaII-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation , 1990, Molecular and cellular biology.

[38]  A. Bird,et al.  High levels of De Novo methylation and altered chromatin structure at CpG islands in cell lines , 1990, Cell.

[39]  A. Wolffe,et al.  How does DNA methylation repress transcription? , 1997, Trends in genetics : TIG.

[40]  E. Li,et al.  Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases , 1998, Nature Genetics.

[41]  M. DePamphilis,et al.  Identifying 5-methylcytosine and related modifications in DNA genomes. , 1998, Nucleic acids research.

[42]  L. Kasturi,et al.  Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. L. Villa.  Fundamental Aspect of Neoplasia , 1976 .

[44]  R. Jaenisch,et al.  Mutagenicity of 5-aza-2'-deoxycytidine is mediated by the mammalian DNA methyltransferase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  T. Dryja,et al.  Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. , 1991, American journal of human genetics.

[46]  T. Dryja,et al.  Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. , 1997, Cancer genetics and cytogenetics.

[47]  R. Weinberg,et al.  Suppression of intestinal neoplasia by DNA hypomethylation , 1995, Cell.

[48]  T. Sakai,et al.  CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. , 1993, Oncogene.

[49]  S. Baylin,et al.  Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon , 1994, Nature Genetics.

[50]  T. Mukai,et al.  A new imprinted gene cloned by a methylation-sensitive genome scanning method. , 1993, Nucleic acids research.

[51]  T. Bestor,et al.  Gene silencing: Methylation meets acetylation , 1998, Nature.

[52]  S. Richard,et al.  Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. , 1997, American journal of human genetics.

[53]  S. Clark,et al.  Sp1 binding is inhibited by (m)Cp(m)CpG methylation. , 1997, Gene.

[54]  G. Liang,et al.  Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. , 1997, Cancer research.

[55]  M. Newton,et al.  Overcoming cellular senescence in human cancer pathogenesis. , 1998, Genes & development.

[56]  C. Harris,et al.  Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. , 1998, Cancer research.

[57]  M. Link,et al.  Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. , 1997, Cancer research.

[58]  A. Riggs,et al.  DNA methylation and gene function. , 1980, Science.

[59]  M. Monk,et al.  Methylation of CpG sites of two X–linked genes coincides with X–inactivation in the female mouse embryo but not in the germ line , 1992, Nature Genetics.

[60]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[61]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[62]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[63]  D. Barlow,et al.  Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal , 1993, Cell.

[64]  A. Feinberg,et al.  Reduced genomic 5-methylcytosine content in human colonic neoplasia. , 1988, Cancer research.

[65]  P. Jones,et al.  The DNA methylation paradox. , 1999, Trends in genetics : TIG.

[66]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[67]  S. Tapscott,et al.  De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[68]  E. Wagner,et al.  Imprinted expression of the Igf2r gene depends on an intronic CpG island , 1997, Nature.

[69]  J. Herman,et al.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[70]  A. Razin,et al.  Gene methylation patterns and expression. , 1993, EXS.

[71]  W. Gerald,et al.  Epigenetic lesions at the H19 locus in Wilms' tumour patients , 1994, Nature Genetics.

[72]  M. Ehrlich,et al.  Effect of site-specific DNA methylation and mutagenesis on recognition by methylated DNA-binding protein from human placenta. , 1986, Nucleic acids research.

[73]  Harris Cc,et al.  Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. , 1998 .

[74]  M. Szyf,et al.  Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[75]  J. Rossignol,et al.  Methylation induced premeiotically in Ascobolus: coextension with DNA repeat lengths and effect on transcript elongation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.